This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy

http://hawaii.eagle-i.net/i/00000130-d350-4939-9953-50a980000000

ClinicalTrials.gov url

http://www.clinicaltrials.gov/ct2/show/NCT00335738?term=NCT00335738&rank=1
Intervention

Carboplatin
Intervention

Etoposide
Intervention

Vincristine sulfate
Additional Topic(s)

Antineoplastic combined chemotherapy protocols
Resource Description

This phase III trial is studying vincristine, carboplatin, and etoposide to see how well they work compared to observation only in treating patients who have undergone surgery for newly diagnosed retinoblastoma.
Contact

Berenberg, Jeffrey
PI

Wilkinson, Robert, M.D.
Topic

connective tissue cancer
Study Population

Males and females up to age 6 with retinoblastoma in one eye only, no more than 4 weeks since surgery to remove the eye, and no previous chemotherapy.
Website(s)

http://www.cancer.gov/clinicaltrials/search/view?cdrid=483043&version=healthprofessional
Funded by

Children's Oncology Group
Phase

Phase 3 clinical trial
Performed by

Clinical Protocol & Data Management Shared Resource

Inferred Types from the eagle-i Ontology (What is an ontology?)

Provenance Metadata About This Resource Record